Medizinische Klinik und Poliklinik IV
  1. Startseite LMU Klinikum
  2. Med IV
  3. Research
  4. Endokrinologie, Diab. &  Stoffwechsel
  5. Endocrine Diagnostics (AG Bidlingmaier)
  6. Publikationen 2023

Publikationen 2023

Amereller, F., Schopohl, J., Störmann, S., Schilbach, K., Bidlingmaier, M., Fischer, M., Rieckmann, P., & Gulde, P. (2023). Can Growth Hormone Lead to a Faster Recovery from Guillain-Barré Syndrome? Case Report of the First Therapeutic Use in One Patient. Case Reports in Neurology, 15(1), 163–171. https://doi.org/10.1159/000530065


Andrews, A., Cottrell, E., Maharaj, A., Ladha, T., Williams, J., Schilbach, K., Kaisinger, L. R., Perry, J. R. B., Metherell, L. A., McCormick, P. J., & Storr, H. L. (2023). Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature. European Journal of Endocrinology, 188(4), 353–365. https://doi.org/10.1093/ejendo/lvad039


Auer, M. K., Paizoni, L., Nowotny, H., Lottspeich, C., Tschaidse, L., Schmidt, H., Bidlingmaier, M., & Reisch, N. (2023). Synthetic glucocorticoids instead of hydrocortisone do not increase mineralocorticoid needs in adult patients with salt wasting congenital adrenal hyperplasia. The Journal of Steroid Biochemistry and Molecular Biology, 230, 106271. https://doi.org/10.1016/j.jsbmb.2023.106271


Bidlingmaier, M., Biller, B. M. K., Clemmons, D., Jørgensen, J. O. L., Nishioka, H., & Takahashi, Y. (2023). Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation. Frontiers in Endocrinology, 14, 1158214. https://doi.org/10.3389/fendo.2023.1158214


Bruedgam, D., Adolf, C., Schneider, H., Schwarzlmueller, P., Mueller, L., Handgriff, L., Bidlingmaier, M., Kunz, S., Zimmermann, P., Deniz, S., Williams, T. A., Beuschlein, F., Reincke, M., & Heinrich, D. A. (2023). Postoperative ACTH-stimulated aldosterone predicts biochemical outcome in primary aldosteronism. European Journal of Endocrinology, 189(6), 611–618. https://doi.org/10.1093/ejendo/lvad159


Buffolo, F., Pecori, A., Reincke, M., Outland, M., Veglio, F., Schwarzlmüller, P., Bidlingmaier, M., Kunz, S., Stremmel, C., Mengozzi, G., Priolo, G., Mulatero, P., Adolf, C., & Monticone, S. (2024). Long-Term Follow-Up of Patients With Elevated Aldosterone-to-Renin Ratio but Negative Confirmatory Test: The Progression of Primary Aldosteronism Phenotypes. Hypertension (Dallas, Tex.: 1979), 81(2), 340–347. https://doi.org/10.1161/HYPERTENSIONAHA.123.21983


Clemmons, D. R., & Bidlingmaier, M. (2023). Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly. Frontiers in Endocrinology, 14, 1266339. https://doi.org/10.3389/fendo.2023.1266339


Dubinski, I., Bechtold, S., Bidlingmaier, M., Reisch, N., & Schmidt, H. (2023). Salivary 17-Hydroxyprogesterone Levels in Children with Congenital Adrenal Hyperplasia: A Retrospective Longitudinal Study Considering Auxological Parameters. Hormone Research in Paediatrics, 96(3), 259–266. https://doi.org/10.1159/000526485


Gong, S., Tetti, M., Kemter, E., Peitzsch, M., Mulatero, P., Bidlingmaier, M., Eisenhofer, G., Wolf, E., Reincke, M., & Williams, T. A. (2023). TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas. Hypertension (Dallas, Tex.: 1979), 80(2), 440–450. https://doi.org/10.1161/HYPERTENSIONAHA.122.19783


Krombholz, S., Thomas, A., Delahaut, P., Bidlingmaier, M., Schilbach, K., Miller, G., & Thevis, M. (2023). A combined top-down and bottom-up LC-HRMS/MS method for the quantification of human growth hormone in plasma and serum. Growth Hormone & IGF Research: Official Journal of the Growth Hormone Research Society and the International IGF Research Society, 72–73, 101560. https://doi.org/10.1016/j.ghir.2023.101560


Kunz, S., Wang, X., Ferrari, U., Drey, M., Theodoropoulou, M., Schilbach, K., Reincke, M., Heier, M., Peters, A., Koenig, W., Zeller, T., Thorand, B., & Bidlingmaier, M. (2024). Age- and sex-adjusted reference intervals for steroid hormones measured by liquid chromatography-tandem mass spectrometry using a widely available kit. Endocrine Connections, 13(1), e230225. https://doi.org/10.1530/EC-23-0225


Mansour, N., Mittermeier, A., Walter, R., Schachtner, B., Rudolph, J., Erber, B., Schmidt, V. F., Heinrich, D., Bruedgam, D., Tschaidse, L., Nowotny, H., Bidlingmaier, M., Kunz, S. L., Adolf, C., Ricke, J., Reincke, M., Reisch, N., Wildgruber, M., & Ingrisch, M. (2023). Integration of clinical parameters and CT-based radiomics improves machine learning assisted subtyping of primary hyperaldosteronism. Frontiers in Endocrinology, 14, 1244342. https://doi.org/10.3389/fendo.2023.1244342


Marques, J., Shokry, E., Uhl, O., Baber, L., Hofmeister, F., Jarmusch, S., Bidlingmaier, M., Ferrari, U., Koletzko, B., & Drey, M. (2023). Sarcopenia: Investigation of metabolic changes and its associated mechanisms. Skeletal Muscle, 13(1), 2. https://doi.org/10.1186/s13395-022-00312-w


Podgórski, R., Sumińska, M., Rachel, M., Pikuła, B., Fichna, P., Bidlingmaier, M., & Fichna, M. (2023). Changes of androgen and corticosterone metabolites excretion and conversion in cystic fibrosis. Frontiers in Endocrinology, 14, 1244127. https://doi.org/10.3389/fendo.2023.1244127


Schluessel, S., Zhang, W., Nowotny, H., Bidlingmaier, M., Hintze, S., Kunz, S., Martini, S., Mehaffey, S., Meinke, P., Neuerburg, C., Schmidmaier, R., Schoser, B., Reisch, N., & Drey, M. (2023). 11-beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) gene expression in muscle is linked to reduced skeletal muscle index in sarcopenic patients. Aging Clinical and Experimental Research, 35(12), 3073–3083. https://doi.org/10.1007/s40520-023-02574-w


Schneider, H., Sarkis, A.-L., Sturm, L., Britz, V., Lechner, A., Potzel, A. L., Müller, L. M., Heinrich, D. A., Künzel, H., Nowotny, H. F., Seiter, T. M., Kunz, S., Bidlingmaier, M., Reincke, M., & Adolf, C. (2023). Moderate dietary salt restriction improves blood pressure and mental well-being in patients with primary aldosteronism: The salt CONNtrol trial. Journal of Internal Medicine, 294(1), 47–57. https://doi.org/10.1111/joim.13618


Störmann, S., & Schilbach, K. (2023). Delving into Acromegaly. Journal of Clinical Medicine, 12(4), 1654. https://doi.org/10.3390/jcm12041654


Then, C., Herder, C., Heier, M., Meisinger, C., Koenig, W., Rathmann, W., Sujana, C., Roden, M., Bidlingmaier, M., Seissler, J., Thorand, B., Peters, A., & Reincke, M. (2023). Association of Aldosterone with Mortality in the General Population. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association, 131(5), 307–313. https://doi.org/10.1055/a-2035-6179


Thieme, D., Krumbholz, A., Bidlingmaier, M., Geffert, C., Hameder, A., Stöver, A., Graw, M., & Keiler, A. M. (2024). Influence of ethanol consumption and food intake on serum concentrations of endogenous steroids. Steroids, 201, 109331. https://doi.org/10.1016/j.steroids.2023.109331


Vogel, F., Braun, L., Zopp, S., Nowak, E., Schreiner, J., Benz, I., Rubinstein, G., Künzel, H., Ritzel, K., Kroiss, M., Honegger, J., Beuschlein, F., Schilbach, K., Teupser, D., Bidlingmaier, M., & Reincke, M. (2023). Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing’s syndrome. European Journal of Endocrinology, 188(4), 375–384. https://doi.org/10.1093/ejendo/lvad041


Zhang, W., Nowotny, H., Theodoropoulou, M., Simon, J., Hemmer, C. M., Bidlingmaier, M., Auer, M. K., Reincke, M., Uhlenhaut, H., & Reisch, N. (2023). E47 as a novel glucocorticoid-dependent gene mediating lipid metabolism in patients with endogenous glucocorticoid excess. Frontiers in Endocrinology, 14, 1249863. https://doi.org/10.3389/fendo.2023.1249863